93 related articles for article (PubMed ID: 10366470)
21. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
Tsanou E; Ioachim E; Briasoulis E; Charchanti A; Damala K; Karavasilis V; Pavlidis N; Agnantis NJ
J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035
[TBL] [Abstract][Full Text] [Related]
22. Tenascin staining positivity and the survival of patients with invasive breast carcinoma.
Shoji T; Kamiya T; Tsubura A; Hamada Y; Hatano T; Hioki K; Morii S
J Surg Res; 1993 Sep; 55(3):295-7. PubMed ID: 7692137
[TBL] [Abstract][Full Text] [Related]
23. A clinicopathological study of the expression of extracellular matrix components in urothelial carcinoma.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Salmas M; Malamou-Mitsi V
BJU Int; 2005 Mar; 95(4):655-9. PubMed ID: 15705098
[TBL] [Abstract][Full Text] [Related]
24. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
[TBL] [Abstract][Full Text] [Related]
25. Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma.
Rintala M; Inki P; Klemi P; Jalkanen M; Grénman S
Gynecol Oncol; 1999 Dec; 75(3):372-8. PubMed ID: 10600292
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
[TBL] [Abstract][Full Text] [Related]
27. Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance.
Ishihara A; Yoshida T; Tamaki H; Sakakura T
Clin Cancer Res; 1995 Sep; 1(9):1035-41. PubMed ID: 9816077
[TBL] [Abstract][Full Text] [Related]
28. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
29. Invasive potency related to RCAS1 expression in uterine cervical cancer.
Sonoda K; Miyamoto S; Hirakawa T; Yagi H; Yotsumoto F; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2005 Oct; 99(1):189-98. PubMed ID: 16112176
[TBL] [Abstract][Full Text] [Related]
30. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
[TBL] [Abstract][Full Text] [Related]
31. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].
Liu R; Pu DM; Cheng YX; Yin L
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1326-9. PubMed ID: 17727777
[TBL] [Abstract][Full Text] [Related]
32. Expression of tenascin in tumors of the esophagus, small intestine and colorectum. An immunohistochemical study.
Broll R; Meyer S; Neuber M; Bruch HP
Gen Diagn Pathol; 1995 Oct; 141(2):111-9. PubMed ID: 8548591
[TBL] [Abstract][Full Text] [Related]
33. The novel serine protease tumor-associated differentially expressed gene-14 (KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer.
Cané S; Bignotti E; Bellone S; Palmieri M; De las Casas L; Roman JJ; Pecorelli S; Cannon MJ; O'brien T; Santin AD
Am J Obstet Gynecol; 2004 Jan; 190(1):60-6. PubMed ID: 14749636
[TBL] [Abstract][Full Text] [Related]
34. Tenascin C expression is upregulated in pancreatic cancer and correlates with differentiation.
Juuti A; Nordling S; Louhimo J; Lundin J; Haglund C
J Clin Pathol; 2004 Nov; 57(11):1151-5. PubMed ID: 15509674
[TBL] [Abstract][Full Text] [Related]
35. The novel serine protease tumor-associated differentially expressed gene-15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinoma.
Santin AD; Cane' S; Bellone S; Bignotti E; Palmieri M; De Las Casas LE; Anfossi S; Roman JJ; O'Brien T; Pecorelli S
Cancer; 2003 Nov; 98(9):1898-904. PubMed ID: 14584072
[TBL] [Abstract][Full Text] [Related]
36. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
Farley J; Gray K; Nycum L; Prentice M; Birrer MJ; Jakowlew SB
Gynecol Oncol; 2000 Aug; 78(2):113-22. PubMed ID: 10926789
[TBL] [Abstract][Full Text] [Related]
37. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
Zhou CY; Yao JF; Chen XD
Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097
[TBL] [Abstract][Full Text] [Related]
38. Beta-catenin expression as a prognostic indicator in cervical adenocarcinoma.
Imura J; Ichikawa K; Takeda J; Fujimori T
Int J Mol Med; 2001 Oct; 8(4):353-8. PubMed ID: 11562771
[TBL] [Abstract][Full Text] [Related]
39. Tenascin expression in normal and abnormal human endometrium.
Sasano H; Nagura H; Watanabe K; Ito K; Tsuiki A; Sato S; Yajima A; Kusakabe M; Sakakura T
Mod Pathol; 1993 May; 6(3):323-6. PubMed ID: 7688462
[TBL] [Abstract][Full Text] [Related]
40. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]